Tech Company Financing Transactions
Labopharm Funding Round
On 6/29/2005, Labopharm secured $10 million in funding from Hercules Technology Growth Capital.
Transaction Overview
Company Name
Announced On
6/29/2005
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Hercules Technology Growth Capital (Parag Shah)
Proceeds Purpose
Proceeds from the financing will be used for general corporate purposes, including the commercialization of the Company's once-daily formulation of tramadol in Europe.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
480 Armand-Frappier Blvd.
Laval QC, H7V 4B4
Canada
Laval QC, H7V 4B4
Canada
Phone
Website
Email Address
Overview
Labopharm Inc. is an international, specialty pharmaceutical company focused on the development of drugs incorporating Contramid, the Company's proprietary advanced controlled-release technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Tripp
Chief Financial Officer
Mark D'Souza
Vice President
Uwe Erbrich
VP - Bus. Development
Gregory Orleski
VP - R & D
Damon Smith
VP - Sales
Mary Heino
Browse more venture capital transactions:
Prev: 6/29/2005: Digital Harbor venture capital transaction
Next: 6/29/2005: Fiberxon venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs